James Meiring

@jamesmeiring.bsky.social

Senior Clinical Lecturer in Infectious Diseases, focusing on enteric fever, vaccines and AMR, at the University of Liverpool, UK based in Blantyre, Malawi

📊 85 studies reviewed on antibiotic use in LMICs post-AWaRe launch. Only 14.1% met UNGA's 70% Access target; 68.2% overused Watch antibiotics. Urgent need for AWaRe-based ASPs! 🦠 #idsky

Increasing the use of the WHO AWaRe system in antibiotic surveillance and stewardship programmes in low- and middle-income countries

AbstractIntroductionAntimicrobial resistance (AMR) presents a major global health threat, driven in part by the inappropriate use of antibiotics including in low- and middle-income countries (LMICs). Improving the quality of antibiotic use is a key rationale for the development of the WHO’s AWaRe (Access, Watch and Reserve) system. There is a need to review the uptake of the AWaRe system since its launch to guide future practice.MethodsA literature search was conducted between 2017, the launch of AWaRe, and 2024. Inclusion criteria were studies that reported on antibiotic use in LMICs using the AWaRe system.ResultsEighty-five studies were included in the review, of which 56.4% focused on antibiotic use trends, with 28.2% reporting on prescribing patterns; 51.7% of the studies included inpatients. Only 14.1% of studies reported meeting the 2024 United Nations General Assembly (UNGA) AMR recommended target of at least 70% of human antibiotic use being Access antibiotics, with a concerning trend of overuse of Watch antibiotics (68.2% of studies). Dispensing practices revealed significant dispensing of antibiotics without prescriptions especially in Pakistan and Bangladesh. Watch antibiotics were more available but also more expensive than Access antibiotics.ConclusionsEncouragingly, many LMICs are now reporting antibiotic use via the AWaRe system, including in antimicrobial stewardship programmes (ASPs). Wide variation exists in the proportion of AWaRe antibiotics used across LMICs, with overuse of Watch antibiotics. There is an urgent need for targeted AWaRe-based ASPs in LMICs to meet recent UNGA recommendations. Improving the use, availability and affordability of Access antibiotics is essential to combat AMR.

academic.oup.com

#Salmonellae infections largely assoc. with negative broader societal impacts, but quality of evidence is low, so hard to make a full value vaccine assessment. Need to start thinking about clinical vaccine trials that measure diverse outcomes beyond disease incidence www.nature.com/articles/s41...

A systematised review and evidence synthesis on the broader societal impact of vaccines against Salmonella - npj Vaccines

npj Vaccines - A systematised review and evidence synthesis on the broader societal impact of vaccines against Salmonella

nature.com

WHO-certified Neglected Tropical Diseases Eliminated in 2024 🇨🇻 🇪🇬-Malaria 🇧🇷 🇹🇱 - Lymphatic filariasis 🇯🇴-Leprosy 🇹🇩-African Trypanosomiasis 🇵🇰 🇮🇳 🇻🇳- Trachoma www.npr.org/sections/goa... #IDSky

9 countries said goodbye to a devastating disease in 2024

Nine countries eliminated a disease in 2024. Here's how Pakistan pulled it off — fulfilling a young boy's dream of eliminating blindness caused by bacterial infections.

npr.org

The fight to rid Pakistan’s coal pits of diseases that plagued British miners a century ago. Ultra-portable, AI driven x-rays have been used to find undiagnosed TB, as miners inhaling soot in Victorian-era conditions are at high risk. ✍️ @sneweyy.bsky.social www.telegraph.co.uk/global-healt...

The fight to rid Pakistan’s coal pits of diseases that plagued British miners a century ago

Ultra-portable, AI driven x-rays have been used to find undiagnosed TB, as miners inhaling soot in Victorian-era conditions are at high risk

telegraph.co.uk

Global trends in antibiotic consumption during 2016–2023 and future projections through 2030. Consumption post-pandemic increasing across LMICs in line with improving economic wealth. Of note - there is no data from almost all of southern, central and eastern #Africa. www.pnas.org/doi/10.1073/...

PNAS

Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans...

pnas.org

The Cost of a Typhoid Conjugate Vaccine Campaign in Malawi........ Only $0.84 a dose! With additional benefit from running an integrated campaign, highlighting to policymakers the potential benefit of delivering multiple antigens in single campaigns. www.sciencedirect.com/science/arti...

Cost of the typhoid conjugate vaccine introduction through an integrated campaign and follow-on routine immunization in Malawi

Malawi introduced typhoid conjugate vaccine (TCV) in 2023 through an integrated campaign delivering TCV alongside other vaccines and interventions (me…

sciencedirect.com